Ferraris Strategic Maneuvers Drive Double-Digit Growth and Strengthen Market Position,

Ferrari s Double-Digit Growth: A Testament to Strategic Product Mix and Quality-Driven Revenues
Maranello, February 2025 Ferrari N.V. (NYSE/EXM: RACE) starts 2025 on a strong note, demonstrating resilience and strategic growth in the luxury automotive sector. With minimal incremental shipments in the first quarter, the company achieved double-digit growth across all key metrics, primarily driven by its assertive focus on a profit-maximizing product mix and a robust demand for vehicle personalizations.

Benedetto Vigna, CEO of Ferrari, highlighted the success of the company s strategy, placing an emphasis on the quality of revenues over sheer quantity. This strategic approach appears to be paying dividends, underscoring Ferrari s enduring appeal and the effective execution of its product strategy. The company continues to enrich its portfolio with six new models set for release this year, including the much-anticipated 296 Speciale, 296 Speciale A, and an innovative reveal of the Ferrari Elettrica.

In alignment with its financial maneuvers, Ferrari participated as a purchaser in Exor N.V. s accelerated bookbuild offering, repurchasing 666,666 common shares for ?300 million. This transaction was financed entirely by Ferrari s existing cash reserves, reinforcing its financial solidity and strategic capital management.

Coinciding with these developments, Ferrari released its 2024 Annual Report and filed Form 20-F with the United States Securities and Exchange Commission, encompassing the fiscal records up to December 31, 2024. Notably, the report includes Ferrari s first-ever Sustainability Statement, adhering to the European Sustainability Reporting Standard (ESRS) requirements on a voluntary basis. This move signifies Ferrari?s commitment to transparency and sustainable practices, aligning with broader industry trends and increasing regulatory expectations.

Overall, Ferrari s recent activities highlight its strategic prowess in navigating the dynamic automotive landscape. By prioritizing a high-quality product mix, executing strategic share repurchases, and committing to sustainability reporting, Ferrari continues to solidify its position as a leader in the global luxury automotive market.

More Ferrari N v 's News

Ferrari N v Ferrari Prepares for 2025 AGM, Emphasizes Financial Strength and Sustainability Commitments, March 5, 2025

Ferrari N v Ferrari Sets Strategic Path with Share Buybacks and Exor Investment Insight, February 27, 2025

Ferrari N v Ferraris 2024 Annual Report Driving Financial Success and Sustainability Forward, February 21, 2025

Ferrari N v Ferraris Resilient Road Navigating Buybacks and Market Challenges, February 17, 2025

Ferrari N v Ferrari N.V. Races to New Highs Fourth Quarter ROE Shatters Records Amid Industry Challenges, February 10, 2025

Ferrari N v Ferrari N.V. (NYSE RACE) has announced another year of exceptional performance, surpassing all targets set ... February 4, 2025

Ferrari N v Ferrari Drives Shareholder Value with Record-Breaking ROE and Strategic Buyback Program, February 3, 2025

Ferrari N v Ferrari Poised to Unveil Strong Financial Performance as it Approaches 2024 Results Announcement January 24, 2025

More Announcement News

Announcement PrimeEnergys Q1 2025 Revenue Growth Amidst Industry Challenges and Strategic Repurchases May 19, 2025

Announcement Dorchester Minerals, L.P. Announces Retirement and Appointment to the Board of Managers May 19, 2025

Announcement ?The Cracks in Everus Investors Rally as Securities Lawsuit Raises Questions about Corporate Integrity? May 16, 2025

Submit

Previous News

Array Technologies Pioneering Green Energy Solutions with Innovation and Resilience

Major Collaboration Announced for 12GW Solar Projects in Emerging Markets

MarketAxess Faces Mixed Signals Ahead of Q1 Earnings Announcement,

s with its launch of a paid consumer subscription for the NurseMagic app, aimed at transforming the nursing professio...

In a notable shift within its executive framework, Ashland Inc. (NYSE ASH) announced that Kevin Willis, the...

Aldeyra Therapeutics Drives Innovation in Dry Eye Disease Treatment Reproxalaps Phase 3 Success and Strategic NDA ...

Centerra Gold Advances Growth Initiatives Through Updated Mineral Resources, Feasibility Studies, and Comprehensive...

Atara Biotherapeutics Turns the Tide FDA Greenlights EBVALLO (tabelecleucel) in a New Era for T-Cell Immunotherapy,

Investing in Futures Fifth Third Banks Heartwarming Educational Gift for Newborns on Fifth Third Day,

Sailing Through the Storm Power Integrations Innovations Amid Market Waves,